Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willa A Hsueh

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Current Opinion in Pharmacology|April 16, 2002
Treatment of type 2 diabetic nephropathy by blockade of the renin-angiotensin system: a comparison of angiotensin-converting-enzyme inhibitors and angiotensin receptor antagonistsWilla A Hsueh
Journal of Clinical Hypertension (Greenwich, Conn.)|April 7, 2011
Renin-Angiotensin-aldosterone system in diabetes and hypertensionWilla A Hsueh, Kathleen Wyne
The American Journal of Cardiology|September 6, 2003
The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular diseaseWilla A Hsueh, Ronald Law
Hypertension (Dallas, Tex. : 1979)|January 21, 2004
Peroxisome proliferator-activated receptor gamma: implications for cardiovascular diseaseWilla A Hsueh, Dennis Bruemmer
The American Journal of Cardiology|September 6, 2003
Role of endothelial dysfunction in insulin resistanceWilla A Hsueh, Manuel J Quiñones
The American Journal of Medicine|December 18, 2003
Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular diseaseChristopher J Lyon, Willa A Hsueh
Current Opinion in Nephrology and Hypertension|February 22, 2002
Peroxisome proliferator-activated receptor-gamma in the renal mesangiumWilla A Hsueh, Susanne B Nicholas
Postgraduate Medicine|August 3, 2010
Prediabetes: the importance of early identification and interventionWilla A Hsueh, Laurie Orloski, Kathleen Wyne
Endocrinology and Metabolism Clinics of North America|September 9, 2006
Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetesFlorian Blaschke, Evren Caglayan, Willa A Hsueh
Journal of Diabetes and Its Complications|March 2, 2002
Vascular protective effects by activation of nuclear receptor PPARgammaShu Wakino, Ronald E Law, Willa A Hsueh
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Current Opinion in Pharmacology|April 16, 2002
Treatment of type 2 diabetic nephropathy by blockade of the renin-angiotensin system: a comparison of angiotensin-converting-enzyme inhibitors and angiotensin receptor antagonistsWilla A Hsueh
Journal of Clinical Hypertension (Greenwich, Conn.)|April 7, 2011
Renin-Angiotensin-aldosterone system in diabetes and hypertensionWilla A Hsueh, Kathleen Wyne
The American Journal of Cardiology|September 6, 2003
The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular diseaseWilla A Hsueh, Ronald Law
Hypertension (Dallas, Tex. : 1979)|January 21, 2004
Peroxisome proliferator-activated receptor gamma: implications for cardiovascular diseaseWilla A Hsueh, Dennis Bruemmer
The American Journal of Cardiology|September 6, 2003
Role of endothelial dysfunction in insulin resistanceWilla A Hsueh, Manuel J Quiñones
The American Journal of Medicine|December 18, 2003
Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular diseaseChristopher J Lyon, Willa A Hsueh
Current Opinion in Nephrology and Hypertension|February 22, 2002
Peroxisome proliferator-activated receptor-gamma in the renal mesangiumWilla A Hsueh, Susanne B Nicholas
Postgraduate Medicine|August 3, 2010
Prediabetes: the importance of early identification and interventionWilla A Hsueh, Laurie Orloski, Kathleen Wyne
Endocrinology and Metabolism Clinics of North America|September 9, 2006
Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetesFlorian Blaschke, Evren Caglayan, Willa A Hsueh
Journal of Diabetes and Its Complications|March 2, 2002
Vascular protective effects by activation of nuclear receptor PPARgammaShu Wakino, Ronald E Law, Willa A Hsueh
Pageof 11